MedPath

Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee

Recruiting
Conditions
Ultrasound Therapy; Complications
Septic Arthritis
Knee Arthritis
Registration Number
NCT04952220
Lead Sponsor
Poitiers University Hospital
Brief Summary

Primary objective: Description of ultrasound abnormalities seen in native septic arthritis of the knee during each visit.

Primary endpoint: Describe the ultrasound abnormalities observed on Day 0, Day 10, 6 weeks, 3 months, 6 months, during native septic arthritis of the knee.

Detailed Description

Secondary Objectives:

1. Search for poor prognostic factors in native septic arthritis of the knee.

2. To look for an association between initial sonographic factors and the use of joint lavage.

3. Look for associations between sonographic signs and clinico-radio-biologic factors at each visit (D10, 6 weeks, 3 months and 6 months)

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Male or female of legal age
  • Bacteriologically proven native septic arthritis
  • Meets the definition of septic arthritis: Bacteriological documentation of joint puncture fluid-Native articulation
  • Free subject, without guardianship or trusteeship, or subordination
  • Non-opposition of the patient after clear and fair information about the study
Exclusion Criteria
  • Presence of material in the affected joint
  • Arthritis with Mycobacterium Tuberculosis.
  • Patients benefiting from a reinforced protection, namely: minors, pregnant and/or breast-feeding women, persons deprived of liberty by a judicial or administrative decision, adults under legal protection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
description of the ultrasound abnormalities seen in native septic arthritis of the kneeDay0, Day 10 or before surgery, 6week, 3months, 6months

Describe the ultrasonographic abnormalities seen in native septic arthritis of the knee

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

CHU de Nantes

🇫🇷

Nantes, Pays De La Loire, France

CH D'Angouleme

🇫🇷

Angoulême, France

CH de La roche-sur-yon

🇫🇷

La Roche-sur-Yon, France

CH De La Rochelle

🇫🇷

La Rochelle, France

CH de Niort

🇫🇷

Niort, France

CHU de Poitiers

🇫🇷

Poitiers, France

CHU de Rennes

🇫🇷

Rennes, France

CHU de Nantes
🇫🇷Nantes, Pays De La Loire, France
Le GOFF Benoit
Contact
:Benoit.LEGOFF@chu-nantes.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.